Literature DB >> 2010907

Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis.

D W Byrd1, R M Roop, H P Veit, G G Schurig.   

Abstract

The viability of four strains of Bordetella bronchiseptica, two strains of B. pertussis and one strain of B. parapertussis exposed to hyperimmune and pre-colostrum porcine serum was examined. Viable cell numbers (cfu/ml) of the B. pertussis strains and a rough strain of B. bronchiseptica (CSU-P-1) decreased by 99% and 99.99%, respectively, after exposure for 1 h to porcine hyperimmune serum. In contrast, smooth B. bronchiseptica strains and the B. parapertussis strain showed no significant decrease in viable cell numbers after the same treatment. B. bronchiseptica strain CSU-P-1 also showed a 99% decrease in viable cell numbers after exposure to pre-colostrum porcine serum for 1 h whereas the other strains tested showed no decrease in viable numbers under the same conditions. Heating the hyperimmune and pre-colostrum serum at 56 degrees C for 30 min resulted in the loss of bactericidal activity suggesting the involvement of complement in both systems. Analysis of silver-stained SDS-PAGE profiles of lipopolysaccharide (LPS) extracted from the bacterial cells indicated that the smooth strains of B. bronchiseptica and the B. parapertussis strain possessed high mol. wt O-side chain-like material, whereas the B. pertussis strains and B. bronchiseptica strain CSU-P-1 did not. Gel filtration of acid-hydrolysed LPS samples indicated two distinct carbohydrate peaks for the strains with high mol. wt O-side chain-like material, whereas the other strains each yielded one distinct peak. Western-blot analysis indicated a positive reaction for anti-B. bronchiseptica antibodies to the high mol. wt O-side chain-like material of all serum-resistant strains used in this study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010907     DOI: 10.1099/00222615-34-3-159

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  8 in total

1.  Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence.

Authors:  N P West; H Jungnitz; J T Fitter; J D McArthur; C A Guzmán; M J Walker
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  Characterization of BrkA expression in Bordetella bronchiseptica.

Authors:  A A Rambow; R C Fernandez; A A Weiss
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

3.  Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.

Authors:  B Trollfors; T Lagergård; J Taranger; E Bergfors; R Schneerson; J B Robbins
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

4.  Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates.

Authors:  Paola Stefanelli; Maurizio Sanguinetti; Cecilia Fazio; Brunella Posteraro; Giovanni Fadda; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  R A Bowden; A Cloeckaert; M S Zygmunt; S Bernard; G Dubray
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Bordetella pertussis acquires resistance to complement-mediated killing in vivo.

Authors:  Elizabeth J Pishko; David J Betting; Christina S Hutter; Eric T Harvill
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Role of Bordetella O antigen in respiratory tract infection.

Authors:  Valorie C Burns; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  Bordetella pertussis autotransporter Vag8 binds human C1 esterase inhibitor and confers serum resistance.

Authors:  Nico Marr; Nita R Shah; Rose Lee; Emma J Kim; Rachel C Fernandez
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.